About: Alseroxylon

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Alseroxylon (Rautensin, Rauwiloid) is a norepinephrine reuptake inhibitor that has been investigated in the treatment of hypertension and angina pectoris and as a sedative in psychoses. It was at one time approved for use in the United States, but has since been discontinued. Alseroxylon is a purified fat-soluble extract of the root of Rauvolfia serpentina, containing reserpine and other nonadrenolytic amorphous alkaloids.

Property	Value
dbo:abstract	Alseroxylon (Rautensin, Rauwiloid) is a norepinephrine reuptake inhibitor that has been investigated in the treatment of hypertension and angina pectoris and as a sedative in psychoses. It was at one time approved for use in the United States, but has since been discontinued. Alseroxylon is a purified fat-soluble extract of the root of Rauvolfia serpentina, containing reserpine and other nonadrenolytic amorphous alkaloids. (en)
dbo:casNumber	8001-95-4 8063-17-0
dbo:chEMBL	1201454
dbo:chemicalFormula	Varies
dbo:drugbank	DB00386
dbo:fdaUniiCode	H192N84N1G
dbo:thumbnail	wiki-commons:Special:FilePath/Reserpine.svg?width=300
dbo:wikiPageID	32844900 (xsd:integer)
dbo:wikiPageLength	2860 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1094171404 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Psychosis dbr:Norepinephrine_reuptake_inhibitor dbr:Alkaloid dbr:Hypertension dbr:Reserpine dbc:Abandoned_drugs dbc:Tryptamine_alkaloids dbr:Angina_pectoris dbc:Indoloquinolizines dbc:Norepinephrine_reuptake_inhibitors dbc:Quinolizidine_alkaloids dbr:Rauvolfia_serpentina
dbp:atcPrefix	2.0
dbp:atcSuffix	AA03 (en)
dbp:caption	Reserpine, the major component of alseroxylon (en)
dbp:casNumber	8001 (xsd:integer) 8063 (xsd:integer)
dbp:chembl	1201454 (xsd:integer)
dbp:chemicalFormula	Varies (en)
dbp:chemspiderid	None (en)
dbp:drugbank	DB00386 (en)
dbp:index2Label	active moiety (en)
dbp:unii	H192N84N1G (en)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	486387027 (xsd:integer)
dbp:watchedfields	changed (en)
dbp:wikiPageUsesTemplate	dbt:Drugbox dbt:Reflist dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Ebicite dbt:Fdacite dbt:Monoamine_reuptake_inhibitors
dcterms:subject	dbc:Abandoned_drugs dbc:Tryptamine_alkaloids dbc:Indoloquinolizines dbc:Norepinephrine_reuptake_inhibitors dbc:Quinolizidine_alkaloids
gold:hypernym	dbr:Inhibitor
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:Abstraction100002137 yago:Alkaloid114712692 yago:Chemical114806838 yago:Compound114818238 yago:Material114580897 yago:Matter100020827 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Relation100031921 yago:WikicatIndoleAlkaloids dbo:Drug yago:Substance100019613
rdfs:comment	Alseroxylon (Rautensin, Rauwiloid) is a norepinephrine reuptake inhibitor that has been investigated in the treatment of hypertension and angina pectoris and as a sedative in psychoses. It was at one time approved for use in the United States, but has since been discontinued. Alseroxylon is a purified fat-soluble extract of the root of Rauvolfia serpentina, containing reserpine and other nonadrenolytic amorphous alkaloids. (en)
rdfs:label	Alseroxylon (en)
owl:sameAs	freebase:Alseroxylon yago-res:Alseroxylon wikidata:Alseroxylon dbpedia-sh:Alseroxylon dbpedia-sr:Alseroxylon https://global.dbpedia.org/id/4PuVv
prov:wasDerivedFrom	wikipedia-en:Alseroxylon?oldid=1094171404&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Reserpine.svg
foaf:isPrimaryTopicOf	wikipedia-en:Alseroxylon
is dbo:wikiPageRedirects of	dbr:Rautensin dbr:Rauwiloid
is dbo:wikiPageWikiLink of	dbr:Rautensin dbr:Rauwiloid
is foaf:primaryTopic of	wikipedia-en:Alseroxylon